These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 6193764)

  • 41. Biogenic amines in seasonal affective disorder: effects of light therapy.
    Rudorfer MV; Skwerer RG; Rosenthal NE
    Psychiatry Res; 1993 Jan; 46(1):19-28. PubMed ID: 7681996
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biogenic amine metabolism in Tourette syndrome.
    Butler IJ; Koslow SH; Seifert WE; Caprioli RM; Singer HS
    Ann Neurol; 1979 Jul; 6(1):37-9. PubMed ID: 292354
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
    Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine.
    Asberg M; Ringberger VA; Sjöqvist F; Thorén P; Träskman L; Tuck JR
    Clin Pharmacol Ther; 1977 Feb; 21(2):201-7. PubMed ID: 13959
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pre-treatment neurotransmitter metabolites and response to imipramine or amitriptyline treatment.
    Maas JW; Kocsis JH; Bowden CL; Davis JM; Redmond DE; Hanin I; Robins E
    Psychol Med; 1982 Feb; 12(1):37-43. PubMed ID: 6177015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Day-to-day intraindividual reliability and interindividual differences in monoamines excretion.
    Curtin F; Walker JP; Schulz P
    J Affect Disord; 1996 Jun; 38(2-3):173-8. PubMed ID: 8791186
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders.
    Vestergaard P; Sørensen T; Hoppe E; Rafaelsen OJ; Yates CM; Nicolaou N
    Acta Psychiatr Scand; 1978 Jul; 58(1):88-96. PubMed ID: 696380
    [No Abstract]   [Full Text] [Related]  

  • 48. [Plasma levels of MHPG, HVA and total 5-HIAA in depression. Preliminary study].
    Raucoules D; Levy C; Azorin JM; Bruno M; Valli M
    Encephale; 1992; 18(6):611-6. PubMed ID: 1285270
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
    Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
    Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome.
    Eriksson E; Alling C; Andersch B; Andersson K; Berggren U
    Neuropsychopharmacology; 1994 Nov; 11(3):201-13. PubMed ID: 7532413
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impacts of age on plasma monoamine metabolite concentrations in a large cohort of healthy individuals.
    Soda E; Miura I; Hoshino H; Kanno-Nozaki K; Ota T; Oguchi H; Watanabe K; Yang Q; Mashiko H; Niwa S
    Psychiatry Res; 2014 Dec; 220(1-2):639-45. PubMed ID: 25200191
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations.
    Heinz A; Weingartner H; George D; Hommer D; Wolkowitz OM; Linnoila M
    Psychiatry Res; 1999 Dec; 89(2):97-106. PubMed ID: 10646828
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationships of Cerebrospinal Fluid Monoamine Metabolite Levels With Clinical Variables in Major Depressive Disorder.
    Yoon HS; Hattori K; Ogawa S; Sasayama D; Ota M; Teraishi T; Kunugi H
    J Clin Psychiatry; 2017; 78(8):e947-e956. PubMed ID: 28749090
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prenatal stress alters brain biogenic amine levels in primates.
    Schneider ML; Clarke AS; Kraemer GW; Roughton EC; Lubach GR; Rimm-Kaufman S; Schmidt D; Ebert M
    Dev Psychopathol; 1998; 10(3):427-40. PubMed ID: 9741675
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuroendocrine and neurochemical measurements in depression.
    Davis KL; Hollister LE; Mathé AA; Davis BM; Rothpearl AB; Faull KF; Hsieh JY; Barchas JD; Berger PA
    Am J Psychiatry; 1981 Dec; 138(12):1555-62. PubMed ID: 6171169
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alterations of fetal brain biogenic amine metabolites by maternal ethanol exposure.
    Okonmah AD; Brown JW; Owasoyo JO; Soliman KF
    Gen Pharmacol; 1988; 19(4):589-93. PubMed ID: 2457539
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of ECT on sleep and CSF biogenic amines in affective illness.
    Hoffmann G; Linkowski P; Kerkhofs M; Desmedt D; Mendlewicz J
    Psychiatry Res; 1985 Nov; 16(3):199-206. PubMed ID: 2418453
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monoamine metabolites in CSF and suicidal behavior.
    Träskman L; Asberg M; Bertilsson L; Sjöstrand L
    Arch Gen Psychiatry; 1981 Jun; 38(6):631-6. PubMed ID: 6166274
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biological markers in depression. Monoamine metabolites in urine of depressed patients and normal subjects.
    Vandel S; Vandel B; Bonin B; Camejo Z; Sandoz M; Allers G; Volmat R
    Pharmacopsychiatry; 1985 Nov; 18(6):347-50. PubMed ID: 2418451
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Indices of noradrenergic output in depression.
    Siever LJ; Uhde TW; Jimerson DC; Lake CR; Kopin IJ; Murphy DL
    Psychiatry Res; 1986 Sep; 19(1):59-73. PubMed ID: 3786600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.